Researchers hope to develop test that could detect early changes in blood flow to heart
A Duke Health pilot project suggests that in the near future, a blood test could show whether arteries carrying blood to the heart are narrow or blocked, a risk factor for heart disease.
According to the 40-person study published in the journal PLOS ONE, emergency patients who underwent a treadmill stress test and showed signs of decreased blood flow to the heart also had changes in five metabolites in their blood within two hours.
A control group of patients with normal stress tests did not show the same metabolite changes.
All study subjects had gone to the emergency department with symptoms of coronary disease, such as chest, jaw and shoulder pain.
The researchers hope a larger study could confirm that acute changes in these fatty acid and amino acid metabolites, which are energy sources for cells, could be an early biological indicator of restricted blood flow that could complement or even replace current tests.
“Cardiologists do a stress test to determine who’s at risk for having heart disease,” said lead author Alexander T. Limkakeng Jr., M.D., lead author of the study and an associate professor of emergency medicine at Duke. “It guides them on whether they need a more invasive study like a catheterization. Augmenting the imaging of a stress test with metabolite biomarkers could make that process more accurate or more efficient.”
Previous research has suggested that metabolites could indicate heart disease, but scientists have yet to uncover the specific metabolomic signature to look for. For the Duke study, scientists evaluated the presence of more than 60 chemicals or compounds in the blood to identify the five specific metabolites that appeared to change in patients with abnormal cardiac stress tests.
The researchers hope to begin a larger study to further test this approach to detecting coronary artery disease, they said.
The Latest on: Metabolite biomarkers
via Google News
The Latest on: Metabolite biomarkers
- SelectScience Article Ranks MOBILion's SLIM Third Among Six Top Technologies at the American Society for Mass Spectrometry Reboot Conferenceon June 24, 2020 at 5:25 pm
MOBILion Systems, Inc., a pioneer in new instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced it was named in a recent SelectScience article as one of the ...
- Alzheimer's May Develop Differently in Womenon June 24, 2020 at 2:48 pm
Women developed Alzheimer's disease-related brain changes earlier than men, a cross-sectional imaging study showed. Compared with their male counterparts, cognitively normal middle-age women showed ...
- Why do more women have Alzheimer's than men? It may be linked to hormonal changes and estrogen loss, says studyon June 24, 2020 at 1:07 pm
The study says changes in brain imaging features, or biomarkers in the brain, suggesting menopausal status may be the best predictor of Alzheimer's related brain changes in women.
- Poxel Announces Positive Pharmacokinetic (PK) / Pharmacodynamic (PD) Study Results for PXL770, a Direct AMPK Activator for the Treatment of NASHon June 23, 2020 at 11:21 pm
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic ...
- Autism 'Signature' Detectable in the Blood?on June 23, 2020 at 10:18 am
Unique metabolic signatures in the blood can accurately identify more than 50% of children with autism, a finding that may lead to earlier diagnosis and novel targeted treatments.
- Unique Metabolic Signatures Associated with Autism Spectrum Disorder (ASD) Detect More than 50% of individuals with ASD in Children’s Autism Metabolome Project (CAMP)on June 18, 2020 at 7:54 am
In a paper published online this week in Autism Research, scientists at NeuroPointDX, a division of Stemina Biomarker Discovery, Inc., in collaboratio ...
- A metabolomics approach to detect objective biomarkers of ASDon June 18, 2020 at 7:14 am
In a paper published online this week in Autism Research, scientists at NeuroPointDX, a division of Stemina Biomarker Discovery, Inc., in collaboration with researchers at the UC Davis MIND Institute ...
- Unique Metabolic Markers Detect Over 50% of Kids Affected by Autismon June 18, 2020 at 5:09 am
Robert Burrier, Ph.D., Chief Operating Officer of Stemina and co-author points out that "Using metabolomics to detect objective biomarkers of ASD is a promising approach because metabolism is ...
- Unique metabolic markers detect over 50% of children affected by autism spectrum disorderon June 18, 2020 at 5:02 am
Robert Burrier, PhD, Chief Operating Officer of Stemina and co-author points out that "Using metabolomics to detect objective biomarkers of ASD is a promising approach because metabolism is sensitive ...
- Virtual metabolic humans, Harvey and Harvetta, novel computational models for personalised medicineon June 4, 2020 at 7:58 am
These virtual humans represent whole-body metabolism, physiology, diet and the gut microbiome. These new models successfully predict known biomarkers of inherited metabolic diseases and enable ...
via Bing News